Big Data in the Healthcare & Pharmaceutical Industry 2017-2030 - Company Profiles and Strategies of Over 240 Big Data Vendors

DUBLIN, August 9, 2017 /PRNewswire/ --

The "Big Data in the Healthcare & Pharmaceutical Industry: 2017 - 2030 - Opportunities, Challenges, Strategies & Forecasts" report from SNS Research has been added to Research and Markets' offering.

Estimates suggest that Big Data investments in the healthcare and pharmaceutical industry will account for nearly $4 Billion in 2017 alone. Led by a plethora of business opportunities for healthcare providers, insurers, payers, government agencies, pharmaceutical companies and other stakeholders, these investments are further expected to grow at a CAGR of more than 15% over the next three years.

The Big Data in the Healthcare & Pharmaceutical Industry: 2017 - 2030 - Opportunities, Challenges, Strategies & Forecasts report presents an in-depth assessment of Big Data in the healthcare and pharmaceutical industry including key market drivers, challenges, investment potential, application areas, use cases, future roadmap, value chain, case studies, vendor profiles and strategies. The report also presents market size forecasts for Big Data hardware, software and professional services investments from 2017 through to 2030. The forecasts are segmented for 8 horizontal submarkets, 5 application areas, 36 use cases, 6 regions and 35 countries.

The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report."

Key Questions Answered

• How big is the Big Data opportunity in the healthcare and pharmaceutical industry?
• How is the market evolving by segment and region?
• What will the market size be in 2020 and at what rate will it grow?
• What trends, challenges and barriers are influencing its growth?
• Who are the key Big Data software, hardware and services vendors and what are their strategies?
• How much are healthcare providers, insurers, payers, pharmaceutical companies and other stakeholders investing in Big Data?
• What opportunities exist for Big Data analytics in the healthcare and pharmaceutical industry?
• Which countries, application areas and use cases will see the highest percentage of Big Data investments in the healthcare and pharmaceutical industry?

Key Findings